Technology | Vascular Access | August 10, 2016

Access Scientific Debuts PowerWand XL Midline Catheter

Catheter designed specifically for component-based, over-wire insertion technique similar to MST

Access Scientific, PowerWand XL midline catheter

August 10, 2016 — Access Scientific introduced the PowerWand XL, a companion to the PowerWand All-in-One, in July. The Powerwand XL is designed specifically for clinicians who prefer to use a component-based, over-wire insertion technique similar to the Modified Seldinger Technique (MST) they currently use.

The XL technique feels similar to the MST, but XL advantages include:

  • Improves clinical outcomes through atraumatic catheter insertion;
  • Designed to reduce risk of deep-vein thrombosis by up to 500 percent. No trimming of catheter necessary;
  • Reduces risk of back leaking. No peel-away sheath;
  • Guidewire extends fully so the catheter does not drag across the intima of the vessel; and
  • Faster and safer because of fewer steps.

As with MST insertions, the XL insertion technique utilizes a 21-gauge safety needle and guidewire to access the vessel. The XL accelerates line placement and makes it safer compared to MST, according to Access Scientific, by eliminating the need for a peelable introducer sheath. Instead, the proprietary PowerWand XL dilator and catheter are inserted directly over the wire and into the bloodstream. This technique eliminates the sheath-related steps in MST that can be associated with such risks as bleeding, back-leaking and vessel damage.

The All-in-One is inserted with the Accelerated Seldinger Technique (AST), which also improves on the MST in speed, number of steps and safety.

Other attributes of the PowerWand XL include:

  • Size: 4Fr and 5Fr;
  • Length: 8 and 10cm;
  • Infection Prevention: Zero BSIs over 12,000 catheter-days;
  • High Flow: Capable of delivering large volumes rapidly, 130-180 ml/min;
  • Power Injectable: 325psi / 8ml per second;
  • Blood Drawable: Allows for blood draws in most patients, 60 – 99 percent; and
  • Patient Satisfaction: Provides patients with one-stick hospitalization.

For more information: www.accessscientific.com

Related Content

Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...
News | Cath Lab | December 18, 2019
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S.
Gallery | Cath Lab | October 31, 2019
This is a photo essay of the interventional cardiology and structural heart technologies on the expo floor and discus
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Cath Lab | October 28, 2019
Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors.
Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

News | Cath Lab | October 28, 2019
October 28, 2019 — Leaders within University Hospitals and the Harrington Heart and Vascular Institute had a vision t
OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019
October 22, 2019 — OmniVision Technologies Inc.
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain
News | Cath Lab | October 02, 2019 | Dave Fornell, Editor
October 2, 2019 — Democratic presidential candidate Sen.
Overlay Init